Wakefield; Darren
Patent Applications and Registrations
Patent applications and USPTO patent grants for Wakefield; Darren.The latest application filed is for "peptide-based in vivo sirna delivery system".
- Wakefield; Darren - Fitchburg WI
- Wakefield; Darren - Madison WI
| Patent | Date |
|---|---|
| Peptide-based in vivo siRNA delivery system Grant 9,107,957 - Rozema , et al. August 18, 2 | 2015-08-18 |
| Peptide-Based In Vivo siRNA Delivery System App 20130281658 - Rozema; David B ; et al. | 2013-10-24 |
| In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages App 20130190484 - Rozema; David ; et al. | 2013-07-25 |
| Endosomolytic polymers Grant 8,217,015 - Rozema , et al. July 10, 2 | 2012-07-10 |
| Membrane active polymers Grant 7,871,818 - Rozema , et al. January 18, 2 | 2011-01-18 |
| Reversible attachment of a membrane active polymer to a polynucleotide Grant 7,816,337 - Rozema , et al. October 19, 2 | 2010-10-19 |
| Polyvinylethers for delivery of polynucleotides to mammalian cells Grant 7,682,626 - Rozema , et al. March 23, 2 | 2010-03-23 |
| Reversible modification of amine-containing compounds Grant 7,442,764 - Rozema , et al. October 28, 2 | 2008-10-28 |
| Labile Linkage for Compound Delivery to a Cell App 20080132689 - Rozema; David B. ; et al. | 2008-06-05 |
| Labile linkage for compound delivery to a cell Grant 7,348,453 - Rozema , et al. March 25, 2 | 2008-03-25 |
| Compounds for targeting hepatocytes in vivo Grant 7,071,163 - Sokoloff , et al. July 4, 2 | 2006-07-04 |
| Reversible modification of amine-containing compounds App 20060122096 - Rozema; David B. ; et al. | 2006-06-08 |
| Reversible modification of membrane interaction Grant 7,019,113 - Rozema , et al. March 28, 2 | 2006-03-28 |
| Reversible modification of membrane interaction App 20050250683 - Rozema, David B. ; et al. | 2005-11-10 |
| Labile linkage for compound delivery to a cell App 20050054604 - Rozema, David B. ; et al. | 2005-03-10 |
| Endosomolytic polymers App 20040198687 - Rozema, David B. ; et al. | 2004-10-07 |
| Reversible attachment of a membrane active polymer to a polynucleotide App 20040162260 - Rozema, David B. ; et al. | 2004-08-19 |
| Polyvinylethers for delivery of polynucleotides to mammalian cells App 20040156909 - Rozema, David B. ; et al. | 2004-08-12 |
| Membrane active polymers App 20040151775 - Rozema, David B. ; et al. | 2004-08-05 |
| Compounds for targeting hepatocytes in vivo App 20040029826 - Sokoloff, Alexander V. ; et al. | 2004-02-12 |
| Compositions and processes for inhibiting gene expression using polynucleotides App 20030224055 - Lewis, David L. ; et al. | 2003-12-04 |
| Reversible modification of membrane interaction App 20030220264 - Rozema, David B. ; et al. | 2003-11-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 